| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |